KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Equity (2018 - 2025)

Historic Return on Equity for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to 0.81%.

  • Bionano Genomics' Return on Equity rose 12900.0% to 0.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.81%, marking a year-over-year increase of 12900.0%. This contributed to the annual value of 1.7% for FY2024, which is 3600.0% down from last year.
  • Bionano Genomics' Return on Equity amounted to 0.81% in Q3 2025, which was up 12900.0% from 1.59% recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Return on Equity registered a high of 0.14% during Q2 2021, and its lowest value of 2.66% during Q4 2024.
  • Its 5-year average for Return on Equity is 1.12%, with a median of 0.66% in 2023.
  • Data for Bionano Genomics' Return on Equity shows a peak YoY increase of 403500bps (in 2021) and a maximum YoY decrease of -1085800bps (in 2021) over the last 5 years.
  • Over the past 5 years, Bionano Genomics' Return on Equity (Quarter) stood at 0.21% in 2021, then plummeted by -134bps to 0.5% in 2022, then crashed by -333bps to 2.16% in 2023, then decreased by -23bps to 2.66% in 2024, then skyrocketed by 70bps to 0.81% in 2025.
  • Its last three reported values are 0.81% in Q3 2025, 1.59% for Q2 2025, and 2.0% during Q1 2025.